Clinical Trials

    A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Progressive Pulmonary Fibrosis (TETON-PPF)

    Investigator: Sandeep Sahay

    Study Coordinator: Rosa Barrosa da Costa

    Status: Enrolling

    ClinicalTrials.gov Number: NCT05943535

    Phone: 713.441.5660

    Protocol Number: PRO00038122

    Description


    Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period.